Precigen, Inc.
PGEN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001356090
In the last 90 days, Precigen, Inc. insiders filed 1 open-market purchase and 6 sales; 210 institutions reported holding it in 13F filings for Q2 2026, worth $799.4M in total; no superinvestor holds it.
13F holders, Q3 2023
Institutional positions in Precigen, Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 138
- +1 vs. Q2 2023
- Shares held
- 60.6M
- +3.20M (+5.6%) vs. Q2 2023
- Total value
- $86.0M
- +$20.0M (+30.4%) vs. Q2 2023
- New holders
- 13
- 41 more added
- Sold out
- 12
- 38 more reduced
1 institution that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PGEN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 210 | $799.4M |
| Q1 2026 | 206 | $516.7M |
| Q4 2025 | 179 | $568.5M |
| Q3 2025 | 167 | $366.2M |
| Q2 2025 | 147 | $116.6M |
| Q1 2025 | 138 | $119.3M |
| Q4 2024 | 133 | $84.8M |
| Q3 2024 | 127 | $71.7M |
| Q2 2024 | 130 | $95.9M |
| Q1 2024 | 129 | $89.4M |
| Q4 2023 | 137 | $83.9M |
| Q3 2023 | 138 | $86.0M |
| Q2 2023 | 138 | $66.0M |
| Q1 2023 | 157 | $65.1M |
| Q4 2022 | 161 | $64.3M |
| Q3 2022 | 165 | $265.0M |
| Q2 2022 | 169 | $182.2M |
| Q1 2022 | 173 | $302.8M |
| Q4 2021 | 168 | $529.9M |
| Q3 2021 | 172 | $690.3M |
| Q2 2021 | 150 | $926.2M |
| Q1 2021 | 166 | $978.6M |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Precigen, Inc.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| CIBC Private Wealth Group, LLC | 166,171 | $236.0K | 0.00% | +166,171 | New |
| Mariner, LLC | 168,224 | $239.1K | 0.00% | +153,591+1,049.6% | Added |
| Raymond James & Associates | 174,859 | $248.3K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 186,035 | $264.0K | 0.00% | +171,220+1,155.7% | Added |
| Alliancebernstein L.P. | 196,750 | $279.4K | 0.00% | −11,850−5.7% | Reduced |
| Rhumbline Advisers | 209,054 | $296.8K | 0.00% | +8,335+4.2% | Added |
| Bank of America Corp | 221,067 | $313.9K | 0.00% | +28,534+14.8% | Added |
| Creative Planning | 229,642 | $326.1K | 0.00% | +2,136+0.9% | Added |
| Cetera Investment Advisers | 240,825 | $342.0K | 0.00% | +4,000+1.7% | Added |
| Citadel Advisors LLC | 296,802 | $421.5K | 0.00% | +271,922+1,092.9% | Added |
| FMR LLC | 313,365 | $445.0K | 0.00% | +111,864+55.5% | Added |
| Advisor Group Holdings, Inc. | 313,653 | $445.4K | 0.00% | +88,887+39.5% | Added |
| Gsa Capital Partners LLP | 334,789 | $475.0K | 0.04% | +334,789 | New |
| Goldman Sachs Group Inc | 384,854 | $546.5K | 0.00% | +72,935+23.4% | Added |
| Sanders Morris Harris LLC | 410,000 | $582.2K | 0.12% | +85,000+26.2% | Added |
| Emfo, LLC | 425,000 | $603.5K | 0.57% | +245,000+136.1% | Added |
| Fore Capital, LLC | 426,791 | $606.0K | 1.11% | −63,209−12.9% | Reduced |
| Bank of New York Mellon Corp | 455,238 | $646.4K | 0.00% | +22,538+5.2% | Added |
| ClariVest Asset Management LLC | 466,144 | $662.0K | 0.04% | −658−0.1% | Reduced |
| Nuveen Asset Management, LLC | 525,028 | $745.5K | 0.00% | −57,456−9.9% | Reduced |
| First Washington CORP | 646,575 | $918.1K | 0.37% | +53,600+9.0% | Added |
| D. E. Shaw & Co., Inc. | 653,692 | $928.2K | 0.00% | +50,947+8.5% | Added |
| GMT Capital Corp | 668,830 | $949.7K | 0.04% | 00.0% | Unchanged |
| Jacobs Levy Equity Management, Inc | 687,794 | $976.7K | 0.01% | −666,781−49.2% | Reduced |
| Opaleye Management Inc. | 928,500 | $1.32M | 0.43% | +928,500 | New |
| MSD Partners, L.P. | 960,000 | $1.36M | 0.11% | 00.0% | Unchanged |
| Morgan Stanley | 972,449 | $1.38M | 0.00% | +32,089+3.4% | Added |
| Charles Schwab Investment Management Inc | 1,060,520 | $1.51M | 0.00% | −37,159−3.4% | Reduced |
| Northern Trust Corp | 1,094,454 | $1.55M | 0.00% | −18,807−1.7% | Reduced |
| Renaissance Technologies LLC | 1,317,290 | $1.87M | 0.00% | −166,300−11.2% | Reduced |
| JPMorgan Chase & Co | 1,343,872 | $1.91M | 0.00% | +141,126+11.7% | Added |
| Millennium Management LLC | 1,422,794 | $2.02M | 0.00% | +1,316,827+1,242.7% | Added |
| Iridian Asset Management LLC | 2,078,220 | $2.95M | 0.60% | −1,255,248−37.7% | Reduced |
| State Street Corp | 2,766,467 | $3.93M | 0.00% | +173,984+6.7% | Added |
| Geode Capital Management, LLC | 2,911,255 | $4.13M | 0.00% | +35,065+1.2% | Added |
| Vanguard Group Inc | 6,950,874 | $9.87M | 0.00% | +130,030+1.9% | Added |
| BlackRock Inc. | 10,456,258 | $14.8M | 0.00% | +89,614+0.9% | Added |
| Patient Capital Management, LLC | 13,753,176 | $19.5M | 1.15% | +2,509,616+22.3% | Added |
| SEI Investments Co | 0 | $0 | 0.00% | −1,045,167−100.0% | Sold out |
| Los Angeles Capital Management LLC | 0 | $0 | 0.00% | −213,294−100.0% | Sold out |
| UBS Asset Management Americas Inc | 0 | $0 | 0.00% | −107,073−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −80,098−100.0% | Sold out |
| Pathstone Family Office, LLC | 0 | $0 | 0.00% | −38,434−100.0% | Sold out |
| AXA S.A. | 0 | $0 | 0.00% | −31,000−100.0% | Sold out |
| Corsair Capital Management, L.P. | 0 | $0 | 0.00% | −20,000−100.0% | Sold out |
| Russell Investments Group, Ltd. | 0 | $0 | 0.00% | −16,556−100.0% | Sold out |
| Mercer Global Advisors Inc | 0 | $0 | 0.00% | −15,402−100.0% | Sold out |
| Headlands Technologies LLC | 0 | $0 | 0.00% | −13,664−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −12,844−100.0% | Sold out |
| Creative Financial Designs Inc | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| BDO Wealth Advisors, LLC | – | – | – | – | Not filed |